GENPF (Genix Pharmaceuticals) Total Assets: $0.03 Mil (As of Jan. 2026)


What is Genix Pharmaceuticals Total Assets?

Genix Pharmaceuticals GENPF Total Assets is $0.03 Mil as of Jan. 2026. The stock has 3 warning signs investors should review.

Genix Pharmaceuticals's Total Assets for the quarter that ended in Jan. 2026 was $0.03 Mil.

During the past 12 months, Genix Pharmaceuticals's average Total Assets Growth Rate was -58.50% per year. During the past 3 years, the average Total Assets Growth Rate was -88.20% per year. During the past 5 years, the average Total Assets Growth Rate was -76.10% per year. During the past 10 years, the average Total Assets Growth Rate was -14.20% per year.

During the past 13 years, Genix Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 678.40%. The lowest was -88.20%. And the median was -11.30%.

Total Assets is connected with ROA %. Genix Pharmaceuticals's annualized ROA % for the quarter that ended in Jan. 2026 was -498.36%. Total Assets is also linked to Revenue through Asset Turnover. Genix Pharmaceuticals's Asset Turnover for the quarter that ended in Jan. 2026 was 0.00.

Genix Pharmaceuticals  (OTCPK:GENPF) Total Assets Explanation

Total Assets is connected with ROA %.

Genix Pharmaceuticals's annualized ROA % for the quarter that ended in Jan. 2026 is

ROA %=Net Income (Q: Jan. 2026 )/( (Total Assets (Q: Oct. 2025 )+Total Assets (Q: Jan. 2026 ))/ count )
=-0.152/( (0.036+0.025)/ 2 )
=-0.152/0.0305
=-498.36 %

Note: The Net Income data used here is four times the quarterly (Jan. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Genix Pharmaceuticals's Asset Turnover for the quarter that ended in Jan. 2026 is

Asset Turnover
=Revenue (Q: Jan. 2026 )/( (Total Assets (Q: Oct. 2025 )+Total Assets (Q: Jan. 2026 ))/ count )
=0/( (0.036+0.025)/ 2 )
=0/0.0305
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Genix Pharmaceuticals Total Assets Related Terms

Genix Pharmaceuticals Total Assets Historical Data

* Premium members only.

The historical data trend for Genix Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals Total Assets Chart

Genix Pharmaceuticals Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.84 3.11 0.16 0.03 0.04

Genix Pharmaceuticals Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.03 0.02 0.04 0.03

Genix Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Genix Pharmaceuticals's Total Assets for the fiscal year that ended in Oct. 2025 is calculated as

Total Assets=Total Equity (A: Oct. 2025 )+Total Liabilities (A: Oct. 2025 )
=-1.014+1.051
=0.04

Genix Pharmaceuticals's Total Assets for the quarter that ended in Jan. 2026 is calculated as

Total Assets=Total Equity (Q: Jan. 2026 )+Total Liabilities (Q: Jan. 2026 )
=-1.068+1.094
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $0.03 Mil mean?
Genix Pharmaceuticals (GENPF) has a Total Assets of $0.03 Mil as of Jan. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Genix Pharmaceuticals and its competitors.
Is Genix Pharmaceuticals' Total Assets too high?
Genix Pharmaceuticals' current Total Assets is $0.03 Mil.
How does Genix Pharmaceuticals' Total Assets compare to ZTS and UTHR?
Genix Pharmaceuticals' Total Assets of $0.03 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Genix Pharmaceuticals and its competitors. Genix Pharmaceuticals's current Total Assets is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genix Pharmaceuticals stock overvalued right now?
Genix Pharmaceuticals (GENPF) has a current Total Assets of $0.03 Mil. The current Total Assets is $0.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Genix Pharmaceuticals (GENPF), the current Total Assets is $0.03 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genix Pharmaceuticals Business Description

Other Exchanges GENX:Canada
Address 1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products. It operates as a formulator, manufacturer, licensor, and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its ophthalmic products portfolio comprises different kinds of eye ointments (pending approval), and eye drops. Geographically the company operates only in Canada.